Search

Your search keyword '"Zastrow, Diane B."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Zastrow, Diane B." Remove constraint Author: "Zastrow, Diane B."
49 results on '"Zastrow, Diane B."'

Search Results

1. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

2. Identification of rare and common regulatory variants in pluripotent cells using population-scale transcriptomics.

3. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

4. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

5. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts.

6. Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review

7. A toolkit for genetics providers in follow‐up of patients with non‐diagnostic exome sequencing

8. ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines

9. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

10. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

11. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

12. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

13. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

14. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

15. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma

16. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

17. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

18. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

19. One is the loneliest number: genotypic matchmaking using the electronic health record

20. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

21. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

22. Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy

23. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

24. ClinGen Variant Curation Interface: A Variant Classification Platform for the Application of Evidence Criteria from ACMG/AMP Guidelines

25. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

26. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

27. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

28. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

29. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

30. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

31. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region

32. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.

33. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

34. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

35. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

36. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

37. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative

38. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

39. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

40. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

41. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

42. Biallelic CRELD1variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

43. IRF2BPL Is Associated with Neurological Phenotypes

44. Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder

45. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

46. Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene.

47. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

48. Cover Image, Volume 39, Issue 11.

49. Exome sequencing identifies de novo pathogenic variants in FBN1 and TRPS1 in a patient with a complex connective tissue phenotype.

Catalog

Books, media, physical & digital resources